134 related articles for article (PubMed ID: 5674960)
1. Hypolipidaemic properties of a new tetralin derivative (CIBA 13,437-Su).
Hess R; Bencze WL
Experientia; 1968 May; 24(5):418-9. PubMed ID: 5674960
[No Abstract] [Full Text] [Related]
2. The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.
Lenz PH; Fleischman AI
Lipids; 1971 Nov; 6(11):783-6. PubMed ID: 5127473
[No Abstract] [Full Text] [Related]
3. Preliminary evaluation of the hypolipidemic effects in man of a new phenolic ether (Su-13437, CIBA).
Best MM; Duncan CH
J Atheroscler Res; 1969; 10(1):103-6. PubMed ID: 5380895
[No Abstract] [Full Text] [Related]
4. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
Timms AR; Kelly LA; Ho RS; Trapold JH
Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
[No Abstract] [Full Text] [Related]
5. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
Tomita T; Takeshita R; Nagakura T; Hayashi E
Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
[No Abstract] [Full Text] [Related]
6. Antilipaemic effect of nicotinamide.
Dalton C
Nature; 1967 Nov; 216(5117):825. PubMed ID: 4229354
[No Abstract] [Full Text] [Related]
7. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
Malhotra SC; Ahuja MM
Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
[No Abstract] [Full Text] [Related]
8. Modification of ethanol-induced changes in rat liver composition by the carbohydrate-fat component of the diet.
Carroll C; Williams L
J Nutr; 1971 Aug; 101(8):997-1012. PubMed ID: 5565101
[No Abstract] [Full Text] [Related]
9. Newer hypolipidemic agents.
Kritchevsky D
Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
[No Abstract] [Full Text] [Related]
10. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
Kokatnur MG; Malcom GT
Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
[No Abstract] [Full Text] [Related]
11. Inhibition of lipid biosynthesis.
Dempsey ME
Ann N Y Acad Sci; 1968 Mar; 148(3):631-46. PubMed ID: 4385358
[No Abstract] [Full Text] [Related]
12. The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.
Mishkel MA; Webb WF
Biochem Pharmacol; 1967 May; 16(5):897-905. PubMed ID: 6036737
[No Abstract] [Full Text] [Related]
13. Lipid effects of a phenolic ether (Su-13437) in the rat: comparison with CPIB.
Best MM; Duncan CH
Atherosclerosis; 1970; 12(2):185-92. PubMed ID: 5493088
[No Abstract] [Full Text] [Related]
14. [Separation of lipids in classes by thin layer chromatogrhy. Fractionation and determination of liver and serum lipids in rats].
Cavina G; Ajello T; Casparrini G; D'Antona A; Moretta L; Moretti G
Ann Ist Super Sanita; 1965; 1(9):566-87. PubMed ID: 5889574
[No Abstract] [Full Text] [Related]
15. Lentysine: a new hypolipidemic agent from a mushroom.
Rokujo T; Kikuchi H; Tensho A; Tsukitani Y; Takenawa T; Yoshida K; Kamiya T
Life Sci; 1970 Apr; 9(7):379-85. PubMed ID: 5463059
[No Abstract] [Full Text] [Related]
16. Effects of compactin (ML-236 B) on biliary lipid composition and cholesterol catabolism in the hamster.
Bosisio E; Cighetti G; Di Padova C; Rovagnati P; Galli Kienle M; Galli G; Paoletti R
Pharmacol Res Commun; 1982 Jul; 14(7):577-92. PubMed ID: 7134247
[No Abstract] [Full Text] [Related]
17. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
Azarnoff DL; Svoboda DJ
Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
[No Abstract] [Full Text] [Related]
18. Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate.
Beckett RB; Weiss R; Stitzel RE; Cenedella RJ
Toxicol Appl Pharmacol; 1972 Sep; 23(1):42-53. PubMed ID: 5071041
[No Abstract] [Full Text] [Related]
19. Effects of Su-13437, a new hypolipidemic drug, upon synthesis in vivo of hepatic and carcass total fatty acids and total cholesterol.
Cenedella RJ
Lipids; 1971 Jul; 6(7):475-80. PubMed ID: 5120787
[No Abstract] [Full Text] [Related]
20. Influence of a terminal period of fasting on the serum and tissue lipid effects of ethyl chlorophenoxyisobutyrate (CPIB).
Duncan CH; Best MM
Metabolism; 1968 Aug; 17(8):681-9. PubMed ID: 5676214
[No Abstract] [Full Text] [Related]
[Next] [New Search]
